Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
2 drugs in development
By Therapeutic Area
top 2
R&D Momentum
45/100
Pipeline Velocity
15/100
Trial Completion Rate
86/100
Pipeline Concentration
38/100
Pipeline Freshness
74/100
Strategic Signals
Activity
Last 14 days
A Remotely Delivered Tai Chi/Qigong Intervention for Older People Living With HIV: A Randomized Clinical Trial
Using Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Depression
Role of Endogenous Opioid Peptides in HIV-associated Chronic Widespread Pain
Clinician Supported Mobile App to Reduce Mental Health Symptoms Among World Trade Center Responders in Florida
Earlier
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)